Document:

EX-10.40

 Exhibit 10.40 

EXECUTION COPY 

ALLSCRIPTS HEALTHCARE SOLUTIONS, INC. 

EMPLOYMENT AGREEMENT 

THIS EMPLOYMENT AGREEMENT (this “Agreement”) is made this 28 day of May, 2013 (the
“Signing Date”), to become effective the 28th day of May, 2013 (the “Effective Date”), by and between Allscripts Healthcare Solutions
Inc., a corporation organized and existing under the laws of the State of Delaware (“Company”), and Brian Farley (“Executive”). 

RECITALS 
 WHEREAS,
commencing on the Effective Date, Company desires to employ Executive subject to the terms and conditions of this Agreement; and 

WHEREAS, Executive desires to be employed by Company subject to the terms and conditions of this Agreement. 

NOW THEREFORE, in consideration of the foregoing premises, of the mutual agreements and covenants contained herein and for other good
and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows: 
 AGREEMENT

 1. Employment. 
 Company
hereby agrees to employ Executive, and Executive hereby accepts employment, as the Senior Vice President, General Counsel and Secretary of Company, pursuant to the terms of this Agreement. Executive shall have the duties and responsibilities and
perform such administrative and managerial services of these positions as are delegated or assigned to Executive by the Chief Executive Officer of Company (the “CEO”) or his delegate from time to time. Executive shall
carry out Executive’s responsibilities hereunder on a full-time basis for and on behalf of Company; provided that Executive shall be entitled to devote time to personal investments, civic and charitable activities, and personal education and
development, so long as such activities do not interfere with or conflict with Executive’s duties hereunder. Notwithstanding the foregoing, Executive agrees that, during the term of this Agreement, Executive shall not act as an officer of any
entity other than Company without the prior written consent of Company. 
 2. Term. 

The term of Executive’s employment by Company under this Agreement (the “Employment Period”) shall commence
on the Effective Date and shall continue in effect through the third (3rd) anniversary of the Effective Date, unless earlier terminated as provided herein. Thereafter, unless Company or Executive shall elect not to renew the Employment Period
upon the expiration of the initial term or any renewal term, which election shall be made by providing written notice of nonrenewal to the other party at least ninety (90) days prior to the expiration of the then current term, the Employment
Period shall be extended for an additional twelve (12) months. If Company elects not to renew the Employment Period at the end of the 

 
initial term or any renewal term, such nonrenewal shall be treated as a termination of the Employment Period and Executive’s employment without Cause by Company for the limited purpose of
determining the payments and benefits available to Executive (i.e., Executive shall be entitled to the severance benefits set forth in Section 4.5.1). If Executive elects not to renew the Employment Period, the same shall constitute a
termination of Executive’s employment and the Employment Period by Executive without Constructive Discharge, and Executive shall only be entitled to the payments and benefits set forth in Section 4.5.3. 

3. Compensation and Benefits. 
 In
consideration for the services Executive shall render under this Agreement, Company shall provide or cause to be provided to Executive the following compensation and benefits: 

3.1 Base Salary. During the Employment Period, Company shall pay to Executive an annual base salary
at a rate of $375,000 per annum, subject to all appropriate federal and state withholding taxes, which base salary shall be payable in accordance with Company’s normal payroll practices and procedures. Executive’s base salary shall be
reviewed annually by the CEO, who shall recommend any increases to the Compensation Committee (the “Compensation Committee”) of the Board of Directors of Company (the “Board”), and may be
increased in the sole discretion of the Board or Compensation Committee based on Executive’s performance during the preceding calendar year. Executive’s base salary, as such base salary may be increased hereunder, is hereinafter referred
to as the “Base Salary.” 
 3.2 Bonuses. 

3.2.1 Performance Bonus. Executive shall be eligible to receive cash bonuses in accordance with this Section 3.2.1 (each a
“Performance Bonus”). The amount and payment of any Performance Bonus shall be subject to a recommendation by the CEO to the Compensation Committee, and such Performance Bonus shall be determined in the sole discretion
of, and based upon criteria selected by, the Compensation Committee. Subject to the foregoing exercise of discretion, Executive’s annual target Performance Bonus shall be 75% of Executive’s Base Salary (the “Target
Performance Bonus”), but may, based on performance, be less than or exceed such amount. Performance Bonuses shall be paid according to the terms of the bonus plan or program in which Executive participates from time to time. 

3.2.2 2013 Performance Bonus. Any Performance Bonus paid for 2013 shall be subject to proration based on Executive’s period
of employment with Company in 2013. 
 3.3 Benefits. During the Employment Period and as otherwise provided hereunder,
Executive shall be entitled to the following: 
 3.3.1 Vacation. Executive shall be entitled to participate in Company’s
vacation policy for similarly-situated employees. 
 3.3.2 Participation in Benefit Plans. Executive shall be entitled to
health and/or dental benefits, including immediate coverage for Executive and Executive’s eligible dependents, which are generally available to similarly situated employees and as provided by Company in accordance with its group health
insurance plan coverage. In addition, Executive 

  
 2 

 
shall be entitled to participate in any profit sharing plan, retirement plan, group life insurance plan or other insurance plan or medical expense plan maintained by Company for its salaried
employees generally, in accordance with the general eligibility criteria therein. 
 3.4 Expenses. Company shall reimburse
Executive for proper and necessary expenses incurred by Executive in the performance of Executive’s duties under this Agreement from time to time upon Executive’s submission to Company of invoices of such expenses in reasonable detail and
subject to all standard policies and procedures of Company with respect to such expenses. 
 3.5 Stock Awards. 

3.5.1 Executive shall be eligible to participate in any applicable stock bonus, stock option, or similar plan implemented by Company and
generally available to its senior executive employees. The amount of any awards made thereunder shall be in the sole discretion of the Board or Compensation Committee. 

3.5.2 Company shall grant to Executive, as soon as practicable on or after the Effective Date: (i) equity-based awards under a
Company stock incentive plan with an aggregate grant-date value of $750,000, which awards shall vest, subject to Executive’s continued employment, 25% on each of the first four anniversaries of the grant date (the “New-Hire
Equity Grant”); and (ii) equity-based awards under a Company stock incentive plan with an aggregate grant-date value of $1,000,000, which awards shall vest on the same time- and performance-based criteria as generally applicable
to equity-based awards to senior executives of Company in 2013 (the “2013 Long-Term Incentive Grant”). It is anticipated that the New-Hire Equity Grant shall be comprised one-half of stock options and one-half of
restricted stock units and the 2013 Long-Term Incentive Grant shall be comprised one-half of stock options and one-half of performance-based restricted stock units, with the actual form of such grants to be in the sole discretion of Company. 

4. Termination of Services Prior To Expiration of Agreement. 

Executive’s employment hereunder and the Employment Period may be terminated at any time as follows (the effective date of such
termination hereinafter referred to as the “Termination Date”): 
 4.1 Termination upon Death or
Disability of Executive. 
 4.1.1 Executive’s employment hereunder and the Employment Period shall terminate immediately
upon the death of Executive. In such event, all rights of Executive and/or Executive’s estate (or named beneficiary) shall cease except for the right to receive payment of the amounts set forth in Section 4.5.4 of the Agreement. 

4.1.2 Company may terminate Executive’s employment hereunder and the Employment Period upon the disability of Executive. For
purposes of this Agreement, Executive shall be deemed to be “disabled” if Executive, as a result of illness or incapacity, shall be unable to perform substantially Executive’s required duties for a period of three
(3) consecutive months or for any aggregate period of three (3) months in any six (6) month period. In the event of a 

  
 3 

 
dispute as to whether Executive is disabled, Company may refer Executive to a licensed practicing physician of Company’s choice, and Executive agrees to submit to such tests and examination
as such physician shall deem appropriate to determine Executive’s capacity to perform the services required to be performed by Executive hereunder. In such event, the parties hereby agree that the decision of such physician as to the disability
of Executive shall be final and binding on the parties. Any termination of the Employment Period under this Section 4.1.2 shall be effected without any adverse effect on Executive’s rights to receive benefits under any disability policy of
Company, but shall not be treated as a termination without Cause. 
 4.2 Termination by Company for Cause. Company may
terminate Executive’s employment hereunder and the Employment Period for Cause (as defined herein) upon written notice to Executive, which termination shall be effective on the date specified by Company in such notice; provided, however, that
Executive shall have a period of ten (10) days (or such longer period not to exceed thirty (30) days as would be reasonably required for Executive to cure such action or inaction) after the receipt of the written notice from Company to
cure the particular action or inaction, to the extent a cure is possible. For purposes of this Agreement, the term “Cause” shall mean: 

4.2.1 the willful or grossly negligent failure by Executive to perform Executive’s duties and obligations hereunder in any material
respect, other than any such failure resulting from the disability of Executive; 
 4.2.2 Executive’s conviction of a crime or
offense involving the property of Company, or any crime or offense constituting a felony or involving fraud or moral turpitude; provided that, in the event that Executive is arrested or indicted for a crime or offense related to any of the
foregoing, then Company may, at its option, place Executive on paid leave of absence, pending the final outcome of such arrest or indictment; 

4.2.3 Executive’s violation of any law, which violation is materially and demonstrably injurious to the operations or reputation of
Company; or 
 4.2.4 Executive’s material violation of any generally recognized policy of Company or Executive’s refusal to
follow the lawful directions of the CEO, or Executive’s insubordination to Executive’s supervisor. 
 4.3 Termination by
Company without Cause; Termination by Executive without Constructive Discharge. Executive may terminate Executive’s employment and the Employment Period at any time for any reason upon thirty (30) days’ prior written notice to
Company. Company may terminate Executive’s employment and the Employment Period without Cause upon thirty (30) days’ prior written notice to Executive. Upon termination of Executive’s employment with Company for any reason,
Executive shall be deemed to have resigned from all positions with the other members of Company and its subsidiaries (provided, that any such deemed resignations shall not affect Executive’s entitlement (if any) to severance pay and benefits
hereunder). 

  
 4 

 4.4 Termination by Executive for Constructive Discharge. 

4.4.1 Executive may terminate Executive’s employment and the Employment Period, in accordance with the process set forth below, as
a result of a Constructive Discharge. For purposes of this Agreement “Constructive Discharge” shall mean the occurrence of any of the following: 
  

	 	(i)	a failure of Company to meet its obligations in any material respect under this Agreement, including, without limitation, (x) any reduction in the Base Salary or (y) any failure to pay the Base Salary (other than,
in the case of clause (y), the inadvertent failure to pay a de minimis amount of the Base Salary, which payment is immediately made by Company upon notice from Executive); 

 

	 	(ii)	a material diminution in or other substantial adverse alteration in the nature or scope of Executive’s responsibilities with Company from those in effect on the Effective Date (excluding, for this purpose, changes
following a Change of Control (x) to Executive’s reporting responsibilities and (y) arising by reason of Company ceasing to be a public company); or 

 

	 	(iii)	without Executive’s prior written agreement, Executive’s principal place of business is moved to a location that is more than fifty (50) miles from Company’s offices located in Chicago,
Illinois. 

 4.4.2 In the event of the occurrence of a Constructive Discharge, Executive shall have the right to
terminate Executive’s employment hereunder and receive the benefits set forth in Section 4.5.1 below, upon delivery of written notice to Company no later than the close of business on the sixtieth (60th) day following the effective
date of the Constructive Discharge; provided, however, that such termination shall not be effective until the expiration of thirty (30) days after receipt by Company of such written notice if Company has not cured such Constructive Discharge
within the thirty (30)-day period. If Company so effects a cure, the Constructive Discharge notice shall be deemed rescinded and of no force or effect. Notwithstanding the foregoing, such notice and lapse of time shall not be required with respect
to any event or circumstance which is the same or substantially the same as an event or circumstance with respect to which notice and an opportunity to cure has been given within the previous six (6) months. The Termination Date of a
Constructive Discharge shall be the date of the Executive’s “separation from service” (within the meaning of Treas. Reg. Section 1.409A-1(h)). 

4.5 Rights upon Termination. Upon termination of Executive’s employment and the Employment Period, the following
shall apply: 
 4.5.1 Termination by Company Without Cause or for Constructive Discharge. If Company terminates
Executive’s employment and the Employment Period without Cause, or if Executive terminates Executive’s employment and the Employment Period as a result of a Constructive Discharge, in each case either (x) prior to a Change of Control,
or (y) after the second anniversary of a Change of Control, Executive shall be entitled to receive 

  
 5 

 
payment of any Base Salary amounts that have accrued but have not been paid as of the Termination Date, and the unpaid Performance Bonus, if any, with respect to the calendar year preceding the
calendar year in which the Termination Date occurs (such Performance Bonus, if any, to be determined in the manner that it would have been determined, and payable at the time it would have been payable, under Section 3.2 had there been no
termination of the Employment Period). In addition, subject to Sections 4.5.2 and 4.7, below, Company shall, subject to Section 7.14, be obligated to pay Executive (or provide Executive with) the following benefits as severance: 

 

	 	(i)	an amount equal to Executive’s Base Salary plus Executive’s Target Performance Bonus, payable in twelve (12) equal monthly installments commencing on the Termination Date, such amount to be payable
regardless of whether Executive obtains other employment and is compensated therefor (but only so long as Executive is not in violation of Section 5 hereof) (with the first two installments to be paid on the sixtieth (60th) day following
the Termination Date and the remaining ten (10) installments being paid on the ten (10) following monthly anniversaries of such date); 

  

	 	(ii)	continuation of Executive’s then current enrollment (including family enrollment, if applicable) in all health and/or dental insurance benefits set forth in Section 3.3.2 for a period of twelve
(12) months following the Termination Date, with Executive’s contribution to such plans as if Executive were employed by Company, such contributions to be paid by Executive in the same period (e.g., monthly, bi-weekly, etc.) as all other
employees of Company (but deductions from Executive’s monthly severance payments may be deemed acceptable for this purpose in the discretion of Company); provided, however that Company may terminate such coverage if payment from Executive is
not made within the COBRA grace period or ten (10) days of the date on which Executive receives written notice from Company that such payment is due, whichever period ends later; and provided, further, that such benefits may be discontinued
earlier to the extent that Executive becomes entitled to comparable benefits from a subsequent employer; in addition, this benefit is contingent upon timely election of COBRA continuation coverage and will run concurrent with the COBRA period; and

  

	 	(iii)	 subject to the terms of any equity award that may exclude special vesting treatment upon a resignation for Constructive Discharge, upon the sixtieth
(60th) day following the Termination Date (or, for awards subject to the satisfaction of a performance condition, subject to the satisfaction of such performance condition and upon the satisfaction of such performance condition (but no earlier
than the sixtieth (60th) day following the Termination Date), and based on the level of performance achieved) a portion of any unvested stock option, restricted stock unit or other equity award granted to Executive shall vest, which portion
shall be the number 

  
 6 

	 	
of shares equal to (a) plus (b) (such sum not to exceed the number of shares that result in the full vesting of any such award) as follows: 

(a) the number of shares that would have vested to Executive per the applicable award as of the one-year anniversary of the
Termination Date had Executive remained continuously employed by Company through such date; plus 
 (b) the number of shares
resulting from the following formula: (x) the number of shares of such award that would vest on the next vesting date of such award immediately following the Termination Date, multiplied by (y) a fraction, the numerator of which is the
number of days elapsed since the last vesting date of such award (or the grant date, if no portion of such award has yet vested), and the denominator of which is the number of days between the last vesting date (or grant date, as the case may be)
and the next vesting date. 
 4.5.2 Severance Upon Termination following a Change of Control. 

 

	 	(i)	If, within the period beginning on the date of a Change of Control through the second anniversary of the Change of Control, Executive terminates Executive’s employment and the Employment Period pursuant to
Section 4.4 or Company terminates Executive’s employment pursuant to Section 4.3, then Executive shall, subject to Sections 4.7 and 7.14, receive the payment and benefits provided in Section 4.5.1; provided, however, that
(A) in place of the twelve (12) monthly payments provided for in Section 4.5.1(i), Executive shall receive a lump sum amount of cash equal to two (2) times the sum of (x) Executive’s Base Salary plus
(y) Executive’s Target Performance Bonus, with such lump sum paid on the sixtieth (60th) day following the Termination Date, and (B) in place of the equity vesting provided for in Section 4.5.1(iii), all unvested equity
awards held by Executive shall vest upon the Termination Date. 

  

	 	(ii)	Anything in this Agreement to the contrary notwithstanding, if (A) a Change of Control occurs, (B) Executive’s employment with Company is terminated by Company without Cause or if Executive terminates his
employment as a result of a Constructive Discharge, in either case within one hundred eighty (180) days prior to the date on which the Change of Control occurs, and (C) it is reasonably demonstrated by Executive that such termination of
employment or events constituting Constructive Discharge was (x) at the request of a third party who had taken steps reasonably calculated to effect a Change of Control or (y) otherwise arose in connection with or in anticipation of a
Change of Control, then for all purposes of this Agreement such Change of Control shall be deemed to have occurred during the Employment Period and the Termination Date shall be deemed to have occurred after the Change of Control, so that

  
 7 

	 	
Executive is entitled to the vesting and other benefits provided by this Section 4.5.2. If Executive is entitled to additional vesting of any equity awards that were cancelled as a result of
Executive’s termination of employment prior to the Change of Control, Company or its successor shall deliver to Executive the consideration Executive would have received in the Change of Control had the cancelled equity awards been outstanding
and vested at the time of the Change of Control. Any additional amounts due Executive as a result of the application of this paragraph to a termination prior to a Change of Control shall be paid to Executive under this Section 4.5.2. in a lump
sum on the sixtieth (60th) day following the Change of Control. 

  

	 	(iii)	For purposes of this Agreement, a “Change of Control” shall mean any one of the following events following the Effective Date: 

(a) the date of acquisition by any person or group other than Company or any subsidiary of Company (and other than any employee benefit plans
(or related trust) of Company or any of its subsidiaries) of beneficial ownership of securities possessing more than thirty percent (30%) of the total combined voting power of Company’s then outstanding voting securities which generally
entitle the holder thereof to vote for the election of directors (“Voting Power”), provided, however, that no Change of Control shall be deemed to have occurred solely by reason of any such acquisition by a corporation
with respect to which, after such acquisition, more than sixty percent (60%) of the then outstanding shares of common stock of such corporation and the Voting Power of such corporation are then beneficially owned, directly or indirectly, by the
persons who were the beneficial owners of the stock and Voting Power of Company immediately before such acquisition, in substantially the same proportions as their ownership immediately before such acquisition; or 

(b) the date the individuals who constitute the Board as of immediately following the Effective Date (the “Incumbent
Board”) cease for any reason other than their deaths to constitute at least a majority of the Board; provided that any individual who becomes a director after the Effective Date whose election or nomination for election by
Company’s stockholders was approved by a vote of at least a majority of the directors then comprising the Incumbent Board shall be considered, for purposes of this Section, as though such individual were a member of the Incumbent Board, but
excluding, for this purpose, any such individual whose initial assumption of office is in connection with an actual or threatened election contest relating to the election of the directors of Company (as such terms are used in Rule 14a-11 under the
1934 Act (defined below)); or 
 (c) Company effects (A) a merger or consolidation of Company with one or more corporations or
entities, as a result of which the holders of the outstanding Voting Stock of Company immediately prior to such merger, reorganization or consolidation hold less than 50% of the Voting Power of the surviving or resulting corporation or entity
immediately after such merger or consolidation; (B) a liquidation or dissolution of Company; or (C) a sale or other disposition of all or substantially all of the assets of Company other than to an entity of which Company owns at least 50%
of the Voting Power. 

  
 8 

 For purposes of the foregoing definition, the terms “beneficially owned” and
“beneficial ownership” and “person” shall have the meanings ascribed to them in SEC rules 13d-5(b) under the 1934 Act, and “group” means two or more persons acting together in such a way to
be deemed a person for purposes of Section 13(d) of the 1934 Act. Further, notwithstanding anything herein to the contrary, the definition of Change of Control set forth herein shall not be broader than the definition of “change in control
event” as set forth under Section 409A of the Code, and the guidance promulgated thereunder, and if a transaction or event does not otherwise fall within such definition of change in control event, it shall not be deemed a Change of
Control for purposes of this Agreement. 
 4.5.3 Termination With Cause by Company or Without Constructive Discharge by
Executive. If Company terminates Executive’s employment and the Employment Period with Cause, or if Executive terminates Executive’s employment and the Employment Period other than as a result of a Constructive Discharge, Company
shall be obligated to pay Executive (i) any Base Salary amounts that have accrued but have not been paid as of the Termination Date; and (ii) subject to Section 7.14, the unpaid Performance Bonus, if any, with respect to the calendar
year preceding the calendar year in which the Termination Date occurs (such Performance Bonus, if any, to be determined in the manner it would have been determined, and payable at the time it would have been payable, under Section 3.2 had there
been no termination of the Employment Period). 
 4.5.4 Termination Upon Death or Disability. If Executive’s employment
and the Employment Period are terminated because of the death or disability of Executive, Company shall, subject to Section 7.14, be obligated to pay Executive or, if applicable, Executive’s estate, the following amounts: (i) earned
but unpaid Base Salary; and (ii) the unpaid Performance Bonus, if any, with respect to the calendar year preceding the calendar year in which the Termination Date occurs (such Performance Bonus, if any, to be determined in the manner it would
have been determined, and payable at the time it would have been payable, under Section 3.2 had there been no termination of the Employment Period). 

4.6 Effect of Notice of Termination. Any notice of termination by Company, whether for Cause or without Cause, may specify that,
during the notice period, Executive need not attend to any business on behalf of Company. 
 4.7 Requirement of a Release;
Exclusivity of Severance Payments under this Agreement. As a condition to the receipt of the severance payments and termination benefits to be provided to Executive pursuant to this Section 4 upon termination of Executive’s
employment, Executive shall execute and deliver to Company (without revoking) a general release of claims against Company and its affiliates in a form reasonably satisfactory to Company within forty-five (45) days following the Termination Date
(provided, that Executive shall not be required to release any rights under this Agreement). In addition, the severance payments and termination benefits to be provided to Executive pursuant to this Section 4 upon termination of
Executive’s employment shall constitute the exclusive payments in the nature of severance or termination pay or salary continuation which shall be due to Executive upon a termination of employment and shall be in lieu of any other such payments
under any severance plan, program, policy or other arrangement which has heretofore been or shall hereafter be established by Company or any of its affiliates. 

  
 9 

 5. Restrictive Covenants. 

The growth and development of Company and its affiliates and subsidiaries (collectively, “Allscripts”) depends to a
significant degree on the possession and protection of its customer list, customer information and other confidential and proprietary information relating to Allscripts’ products, services, methods, pricing, costs, research and development and
marketing. All Allscripts employees and others engaged to perform services for Allscripts have a common interest and responsibility in seeing that such customer information and other confidential information is not disclosed to any
unauthorized persons or used other than for Allscripts’ benefit. This Section 5 expresses a common understanding concerning Company’s and Executive’s mutual responsibilities. Therefore, in consideration for Company’s
agreement to employ Executive and grant Executive access to its confidential information and customer relationships, and for other good and valuable consideration from Company, including, without limitation, compensation, benefits, raises, bonus
payments or promotions, the receipt and sufficiency of which are hereby acknowledged, Executive covenants and agrees as follows, which covenant and agreement is essential to this Agreement and Executive’s employment with Company: 

5.1 Non-Solicitation; No-Hire. Executive acknowledges that the identity and particular needs of Allscripts’ customers are
not generally known in the health care information technology and consulting industry and were not known to Executive prior to Executive’s employment with Allscripts; that Allscripts has near permanent relationships with, and a proprietary
interest in the identity of, its customers and their particular needs and requirements; and that documents and information regarding Allscripts’ pricing, sales, costs and specialized requirements of Allscripts’ customers are highly
confidential and constitute trade secrets. Accordingly, Executive covenants and agrees that during the Employment Period and for a period of twelve (12) months after the Termination Date, regardless of the reason for such termination, Executive
will not, except on behalf of Allscripts during and within the authorized scope of Executive’s employment with Allscripts, directly or indirectly; (i) call on, solicit or otherwise deal with any accounts, customers or prospects of
Allscripts which Executive called upon, contacted, solicited, sold to, or about which Executive learned Confidential Information (as defined herein) while employed by Allscripts, for the purpose of soliciting, selling and/or providing, to any such
account, customer or prospect, any products or services similar to or in competition with any products or services then-being represented or sold by Allscripts; and (ii) solicit, or accept if offered to Executive, with or without solicitation,
the services of any person who is an employee of Allscripts, nor solicit any employee of Allscripts to terminate employment with Allscripts, nor agree to hire on behalf of Executive or any entity or other person any employee of Allscripts into
employment with Executive or any other person or entity. Executive agrees not to solicit, directly or indirectly, such accounts, customers, prospects or employees for Executive or for any other person or entity. For purposes of this paragraph,
“prospects” means entities or individuals which have had more than de minimus contact with Allscripts in the context of entering into a relationship with Allscripts being a provider of products or services to such entity or
individual. 
 5.2 Non-Interference with Business Relationships. Executive covenants and agrees that during the Employment
Period and for a period of twelve (12) months after the Termination Date, regardless of the reason for such termination, Executive will not interact with any person 

  
 10 

 
or entity with which Allscripts has a business relationship, or with which Allscripts is preparing to have a business relationship, with the intent of affecting such relationship or intended
relationship in a manner adverse to Allscripts. 
 5.3 Non-Competition. Executive agrees that during the Employment Period and
for a period of twelve (12) months after the Termination Date, regardless of the reason for such termination, Executive shall not, directly or indirectly, for Executive’s own benefit or for the benefit of others, render services for a
Competing Organization in connection with Competing Products or Services anywhere within the Restricted Territory. These prohibitions apply regardless of where such services physically are rendered. 

For purposes of this Agreement, “Competing Products or Services” means products, processes, or services of any person or
organization other than Allscripts, in existence or under development, which are substantially the same, may be substituted for, or applied to substantially the same end use as any product, process, or service of Allscripts with which Executive
works or worked during the time of Executive’s employment with Allscripts or about which Executive acquires or acquired Confidential Information through Executive’s work with Allscripts. 

For purposes of this Agreement, “Competing Organization” means persons or organizations, including Executive, engaged in, or
about to become engaged in research or development, production, distribution, marketing, providing or selling of a Competing Product or Service. 

For purposes of this Agreement, “Restricted Territory” means either: (i) during Executive’s employment with
Allscripts, anywhere in the world; or (ii) after cessation of Executive’s employment with Allscripts, then, in descending order of preference based on legal enforceability, (A) within the United States (including its territories) and
within each country in which Allscripts has conducted business or directed material resources in soliciting business in the prior twenty-four (24) month period, (B) within the United States (including its territories) and within any other
country that at any time was within the scope of Executive’s employment with Allscripts, (C) within any country that at any time during the last two (2) years of Executive’s employment with Allscripts was within the scope of such
employment, or (D) within any geographic region(s) that at any time during the last two (2) years of Executive’s employment with Allscripts was within the scope of such employment. Executive agrees that in the event a court determines
the length of time or the geographic area or activities prohibited under this Section 5 are too restrictive to be enforceable, the court may reduce the scope of the restriction to the extent necessary to make the restriction enforceable. 

5.4 Reasonableness of Restriction. Executive acknowledges that the foregoing non-solicitation, non-competition and
non-interference restrictions placed upon Executive are necessary and reasonable to avoid the improper disclosure or use of Confidential Information, and that it has been made clear to Executive that Executive’s compliance with Section 5
of this Agreement is a material condition to Executive’s employment by Company. Executive further acknowledges and agrees that, if Executive breaches any of the requirements of Section 5.1, 5.2 or 5.3, the twelve (12) month restricted
period set forth therein shall be tolled during the time of such breach. 

  
 11 

 Executive further acknowledges and agrees that Allscripts has attempted to impose the
restrictions contained hereunder only to the extent necessary to protect Allscripts from unfair competition and the unauthorized use or disclosure of Confidential Information. However, should the scope or enforceability of any restrictive covenant
be disputed at any time, Executive specifically agrees that a court may modify or enforce the covenant to the full extent it believes to be reasonable under the circumstances existing at the time. 

5.5 Non-Disclosure. Executive further agrees that, other than as needed to fulfill the authorized scope of Executive’s
duties with Allscripts, Executive will not during the Employment Period or thereafter use for himself or for others or divulge or convey to any other person (except those persons designated by Allscripts) any Confidential Information obtained by
Executive during the period of Executive’s employment with Allscripts. Executive agrees to observe all Company policies and procedures concerning such Confidential Information. Executive agrees that, except as may be permitted by written
Company policies, Executive will not remove from Company’s premises any of such Confidential Information without the written authorization of Company. Executive’s obligations under this Agreement will continue with respect to Confidential
Information until such information becomes generally available from public sources through no fault of Executive’s. During the Employment Period and thereafter Executive shall not disclose to any person the terms and conditions of
Executive’s employment by Allscripts, except: (i) to close family members, (ii) to legal and accounting professionals who require the information to provide a service to Executive, (iii) as required by law or (iv) in order
to inform a prospective or actual subsequent employer of Executive’s duties and obligations under this Agreement. If Executive is requested, becomes legally compelled by subpoena or otherwise, or is required by a regulatory body to make any
disclosure that is prohibited by this Section 5.5, Executive will promptly notify Company so that Allscripts may seek a protective order or other appropriate remedy if Allscripts deems such protection or remedy necessary under the
circumstances. Subject to the foregoing, Executive may furnish only that portion of Confidential Information that Executive is legally compelled or required to disclose. The restrictions set forth herein are in addition to and not in lieu of any
obligations Executive may have by law with respect to Confidential Information, including any obligations Executive may have under the Uniform Trade Secrets Act and/or similar statutes as applicable in the state of Executive’s residence and/or
the state of Executive’s primary work location. 
 5.6 Definition of Confidential Information. As used herein,
“Confidential Information” shall include, but is not limited to, the following categories of information, knowledge, or data currently known or later developed or acquired relating to Allscripts’ business or received by
Allscripts in confidence from or about third parties, in each case when the same is not in the public domain or otherwise publicly available (other than as result of a wrongful act of an agent or employee of Allscripts): 

5.6.1 Any information concerning Allscripts’ products, business, business relationships, business plans or strategies, marketing
plans, contract provisions, actual or prospective suppliers or vendors, services, actual or anticipated research or development, new product development, inventions, prototypes, models, solutions, discussion guides, documentation, techniques, actual
or planned patent applications, technological or engineering data, formulae, processes, designs, production plans or methods, or any related technical or manufacturing know-how or other information; 

  
 12 

 5.6.2 Any information concerning Allscripts’ financial or profit data, pricing or
cost formulas, margins, marketing information, sales representative or distributor lists, or any information relating to corporate developments (including possible acquisitions or divestitures); 

5.6.3 Any information concerning Allscripts’ current or prospective customer lists or arrangements, equipment or methods used or
preferred by Allscripts’ customers, or the patients of customers; 
 5.6.4 Any information concerning Allscripts’ use of
computer software, source code, object code, or algorithms or architecture retained in or related to Allscripts’ computer or computer systems; 

5.6.5 Any personal or performance information about any Allscripts’ employee; 

5.6.6 Any information supplied to or acquired by Allscripts under an obligation to keep such information confidential, including without
limitation Protected Health Information (PHI) as that term is defined by the Health Insurance Portability and Accountability Act (HIPAA); 

5.6.7 Any information, whether or not designated as confidential, obtained or observed by Executive or other Allscripts employees during
training sessions related to Executive’s work for Allscripts; and 
 5.6.8 Any other information treated as trade secrets or
otherwise confidential by Allscripts. 
 Executive hereby acknowledges that some of this information may not be a “trade secret”
under applicable law. Nevertheless, Executive agrees not to disclose it. 
 5.7 Inventions, Discoveries, and Work for Hire.
Executive recognizes and agrees that all ideas, works of authorship, inventions, patents, copyrights, designs, processes (e.g., development processes), methodologies (e.g., development methodologies), machines, manufactures, compositions of
matter, enhancements, and other developments or improvements and any derivative works based thereon, including, without limitation, potential marketing and sales relationships, research, plans for products or services, marketing plans, computer
software (including source code and object code), computer programs, original works of authorship, characters, know-how, trade secrets, information, data, developments, discoveries, improvements, modifications, technology and algorithms, whether or
not subject to patent or copyright protection (the “Inventions”) that (i) were made, conceived, developed, authored or created by Executive, alone or with others, during the time of Executive’s employment, whether
or not during working hours, that relate to the business of Allscripts or to the actual or demonstrably anticipated research or development of Allscripts, (ii) were used by Executive or other personnel of Allscripts during the time of
Executive’s employment, even if such Inventions were made, conceived, developed, authored or created by Executive prior to the start of Executive’s employment, (iii) are made, conceived, developed, authored or created by Executive,
alone or with others, within two (2) years from the Termination Date and that relate to the business of Allscripts or to the actual or demonstrably anticipated research or development of Allscripts, or (iv) result from any work performed
by Executive for Allscripts, (collectively with (i)-(iii), the “Company Inventions”) are the sole and exclusive property of Company. 

  
 13 

 Notwithstanding the foregoing, Company Inventions do not include any Inventions made, conceived,
developed, authored or created by Executive, alone or with others, for which no equipment, supplies, facility or trade secret information of Allscripts was used and which were developed entirely on Executive’s own time, unless (1) the
Invention relates (A) to the business of Allscripts, or (B) to the actual or demonstrably anticipated research or development of Allscripts, or (2) the Company Invention results from any work performed by Executive for Allscripts.

 For the avoidance of doubt, Executive expressly disclaims any and all right title and interest in and to all Company Inventions,
Executive acknowledges that Executive has and shall forever have no right, title or interest in or to any patents, copyrights, trademarks, industrial designs or other rights in connection with any Company Inventions. 

Executive hereby assigns to Company all present and future right, title and interest Executive has or may have in and to the Company
Inventions. Executive further agrees that (i) Executive will promptly disclose all Company Inventions to Allscripts; and (ii) all of the Company Inventions, to the extent protectable under copyright laws, are “works made for
hire” as that term is defined by the Copyright Act, 17 U.S.C. § 101, et seq. 
 At the request of and without charge to
Company, Executive will do all things deemed by Company to be reasonably necessary to perfect title to the Company Inventions in Company and to assist in obtaining for Company such patents, copyrights or other protection in connection therewith as
may be provided under law and desired by Company, including but not limited to executing and signing any and all relevant applications, assignments, or other instruments. Executive further agrees to provide, at Company’ request, declarations or
affidavits and to give testimony, in depositions, hearings or trials, in support of inventorship. These obligations continue even after the Termination Date. Company agrees that Executive will be reimbursed for reasonable expenses incurred in
providing such assistance to Company. In the event Company is unable, after reasonable effort, to secure Executive’s signature on any document or documents needed to apply for or prosecute any patent, copyright or other right or protection
relating to any Company Invention, for any reason whatsoever, Executive hereby irrevocably designates and appoints Company and its duly authorized officers and agents as Executive’s agent and attorney-in-fact to act for and on Executive’s
behalf to execute and file any such application or other document and to do all other lawfully permitted acts to further the prosecution and issuance of patents, copyrights, or similar protections thereon with the same legal force and effect as if
executed by Executive. 
 For purposes of this Agreement, a Company Invention shall be deemed to have been made during Executive’s
employment if, during such period, the Company Invention was conceived, in part or in whole, or first actually reduced to practice or fixed in a tangible medium during Executive’s employment with Company. Executive further agrees and
acknowledges that any patent or copyright application filed within one (1) year after the Termination Date shall be presumed to relate to a Company Invention made during the term of Executive’s employment unless Executive can provide
evidence to the contrary. 

  
 14 

 5.8 Prior Employment. Executive hereby agrees that during the course and scope of
the employment relationship with Company, Executive shall neither disclose nor use any confidential information, invention, or work of authorship derived from, developed or obtained in any prior employment relationship, and understands that any such
disclosure or use would be injurious to the economic and legal interests of Company. Executive represents he has informed Company of, and provided Company with copies of, any non-competition, non-solicitation, confidentiality, work-for-hire or
similar agreements to which Executive is subject or may be bound. Executive further represents and agrees that, if any prior employer commences any legal proceeding in connection with any restrictive covenant, non-solicitation, non-disclosure, or
non-competition agreement, (i) Executive shall be entirely responsible for his own legal fees in connection with the defense of same; and (ii) Executive shall indemnify and hold harmless Company, its affiliates, suppliers, vendors,
customers and clients from any costs and liability arising therefrom including, but not limited to, legal fees, expenses, licenses, royalty payments, and any other damages. 

5.9 Return of Data. In the event of the termination of Executive’s employment with Company for any reason whatsoever,
Executive agrees to deliver promptly to Company all formulas, correspondence, reports, computer programs and similar items, customer lists, marketing and sales data and all other materials pertaining to Confidential Information, and all copies
thereof, obtained by Executive during the period of Executive’s employment with Company which are in Executive’s possession or under his control. Executive further agrees that he will not make or retain any copies of any of the foregoing
and will so represent to Company upon termination of his employment. 
 5.10 Non-Disparagement. Executive agrees that during
the Employment Period and for a period of twenty-four (24) months thereafter, Executive will not make any statement, nor imply any meaning through Executive’s action or inaction, if such statement or implication would be adverse to the
interests of Allscripts, its customers or its vendors or may reasonably cause any of the foregoing embarrassment or humiliation; nor will Executive otherwise cause or contribute to any of the foregoing being held in disrepute by the public or any
other Allscripts customer(s), vendor(s) or employee(s). The restrictions of this Section 5.10 shall apply to, but are not limited to, communication via the Internet, any intranet, or other electronic means, such as social media web sites,
electronic bulletin boards, blogs, email messages, text messages or any other electronic message. 
 5.11 Injunctive Relief and
Additional Remedies for Breach. Executive further expressly acknowledges and agrees that any breach or threatened breach of the provisions of this Section 5 shall entitle Allscripts, in addition to any other legal remedies available to
it, to obtain injunctive relief, to prevent any violation of this Section 5 without the necessity of Allscripts posting bond or furnishing other security and without proving special damages or irreparable injury, Executive recognizes,
acknowledges and agrees that such injunctive relief is necessary to protect Allscripts’ interest. Executive understands that in addition to any other remedies available to Allscripts at law or in equity or under this Agreement for violation of
this Agreement, other agreements or compensatory or benefit arrangements Executive has with Allscripts may include provisions that specify certain consequences thereunder that will result from Executive’s violation of this Agreement, which
consequences may include repaying Allscripts or foregoing certain equity awards or monies, and any such consequences shall not be 

  
 15 

 
considered by Executive or any trier of fact as a forfeiture, penalty, duplicative remedy or exclusive remedy. Notwithstanding Section 7.9, the exclusive venue for any action for injunctive
or declaratory relief with respect to this Section 5 shall be the state or federal courts located in Cook County, Illinois. Company and Executive hereby irrevocably consent to any such courts’ exercise of jurisdiction over them for such
purpose. 
 5.12 Notification to Third Parties. Company may, at any time during or after the termination of Executive’s
employment with Company, notify any person, corporation, partnership or other business entity employing or engaging Executive or evidencing an intention to employ or engage Executive as to the existence and provisions of this Agreement. 

6. No Set-Off or Mitigation. 

Company’s obligation to make the payments provided for in this Agreement and otherwise to perform its obligations hereunder shall not be
affected by any set-off, counterclaim, recoupment, defense or other claim, right or action which Company may have against Executive or others. In no event shall Executive be obligated to seek other employment or take any other action by way of
mitigation of the amounts payable to Executive under any of the provisions of this Agreement and, except as otherwise provided herein, such amounts shall not be reduced whether or not Executive obtains other employment. 

7. Miscellaneous. 
 7.1 Valid
Obligation. This Agreement has been duly authorized, executed and delivered by Company and has been duly executed and delivered by Executive and is a legal, valid and binding obligation of Company and of Executive, enforceable in accordance
with its terms. 
 7.2 No Conflicts. Executive represents and warrants that the performance by Executive of Executive’s
duties hereunder will not violate, conflict with, or result in a breach of any provision of any agreement to which Executive is a party. 

7.3 Applicable Law. This Agreement shall be construed in accordance with the laws of the State of Illinois, without reference to
Illinois’ choice of law statutes or decisions. 
 7.4 Severability. The provisions of this Agreement shall be deemed
severable, and the invalidity or unenforceability of any one or more of the provisions hereof shall not affect the validity or enforceability of any other provision. In the event any clause of this Agreement is deemed to be invalid, the parties
shall endeavor to modify that clause in a manner which carries out the intent of the parties in executing this Agreement. 
 7.5 No
Waiver. The waiver of a breach of any provision of this Agreement by any party shall not be deemed or held to be a continuing waiver of such breach or a waiver of any subsequent breach of any provision of this Agreement or as nullifying the
effectiveness of such provision, unless agreed to in writing by the parties. 

  
 16 

 7.6 Notices. All demands, notices, requests, consents and other communications
required or permitted under this Agreement shall be in writing and shall be personally delivered or sent by facsimile machine (with a confirmation copy sent by one of the other methods authorized in this Section), or by commercial overnight delivery
service, to the parties at the addresses set forth below: 
  

			
	To Company:	  	Allscripts Healthcare Solutions, Inc.
		  	 222 Merchandise Mart Plaza
 Suite 2024

Chicago, IL 60654
 Attention: Chief Executive
Officer

		
	To Executive:	  	 At the address and/or fax number most recently

contained in Company’s records

 Notices shall be deemed given upon the earliest to occur of (i) receipt by the party to whom such notice is directed, if
hand delivered; (ii) if sent by facsimile machine, on the day (other than a Saturday, Sunday or legal holiday in the jurisdiction to which such notice is directed) such notice is sent if sent (as evidenced by the facsimile confirmed receipt)
prior to 5:00 p.m. Central Time and, if sent after 5:00 p.m. Central Time, on the day (other than a Saturday, Sunday or legal holiday in the jurisdiction to which such notice is directed) after which such notice is sent; or (iii) on the first
business day (other than a Saturday, Sunday or legal holiday in the jurisdiction to which such notice is directed) following the day the same is deposited with the commercial carrier if sent by commercial overnight delivery service. Each party, by
notice duly given in accordance therewith, may specify a different address for the giving of any notice hereunder. 
 7.7 Assignment
of Agreement. This Agreement shall be binding upon and inure to the benefit of Executive and Company, their respective successors and permitted assigns and Executive’s heirs and personal representatives. Neither party may assign any
rights or obligations hereunder to any person or entity without the prior written consent of the other party. This Agreement shall be personal to Executive for all purposes. 

7.8 Entire Agreement; Amendments. Except as otherwise provided herein, this Agreement contains the entire understanding between
the parties, and there are no other agreements or understandings between the parties with respect to Executive’s employment by Company and Executive’s obligations thereto. Executive acknowledges that Executive is not relying upon any
representations or warranties concerning Executive’s employment by Company except as expressly set forth herein. No amendment or modification to the Agreement shall be valid except by a subsequent written instrument executed by the parties
hereto. 
 7.9 Dispute Resolution and Arbitration. The following procedures shall be used in the resolution of disputes: 

7.9.1 Dispute. In the event of any dispute or disagreement between the parties under this Agreement (excluding an action for
injunctive or declaratory relief as provided in Section 5.11), the disputing party shall provide written notice to the other party that such dispute exists. The parties will then make a good faith effort to resolve the dispute or disagreement.
If the dispute is not resolved upon the expiration of fifteen (15) days from the date a party receives such notice of dispute, the entire matter shall then be submitted to arbitration as set forth in Section 7.9.2. 

  
 17 

 7.9.2 Arbitration. If the dispute or disagreement between the parties has not been
resolved in accordance with the provisions of Section 7.9.1 above, then any such controversy or claim arising out of or relating to this Agreement, or the breach thereof, shall be settled by arbitration to be held in Chicago, Illinois, in
accordance with the rules of the American Arbitration Association then in effect. Any decision rendered herein shall be final and binding on each of the parties and judgment may be entered thereon in the appropriate state or federal court. The
arbitrators shall be bound to strict interpretation and observation of the terms of this Agreement. Company shall pay the costs of arbitration. 

7.10 Survival. For avoidance of doubt, the provisions of Sections 4.5, 5 and 7 of this Agreement shall survive the expiration or
earlier termination of the Employment Period. 
 7.11 Headings. Section headings used in this Agreement are for convenience of
reference only and shall not be used to construe the meaning of any provision of this Agreement. 
 7.12 Counterparts. This
Agreement may be executed in counterparts, each of which shall be deemed an original, but both of which together shall constitute one and the same instrument. Signatures delivered via facsimile or electronic file shall be the same as original
signatures. 
 7.13 Taxes. Executive shall be solely responsible for taxes imposed on Executive by reason of any
compensation and benefits provided under this Agreement and all such compensation and benefits shall be subject to applicable withholding. 

7.14 Internal Revenue Code Section 409A. 

7.14.1 It is intended that this Agreement will comply with Internal Revenue Code Section 409A and any regulations and guidelines
issued thereunder (collectively “Section 409A”) to the extent this Agreement is subject thereto. This Agreement shall be interpreted on a basis consistent with such intent. 

7.14.2 If any payments or benefits provided to Executive by Company, either per this Agreement or otherwise, are non-qualified deferred
compensation subject to, and not exempt from, Section 409A (“Subject Payments”), the following provisions shall apply to such payments and/or benefits: 

 

	 	(i)	For payments and benefits triggered by termination of employment, reference to Executive’s “termination of employment” (and corollary terms) with Company shall be construed to refer to Executive’s
“separation from service” from Company (with such phrase determined under Treas. Reg. Section 1.409A-1(h), as uniformly applied by Company) in tandem with Executive’s termination of employment with Company. 

  
 18 

	 	(ii)	If Executive is deemed on the date of Executive’s “separation from service” to be a “specified employee” (within the meaning of Treas. Reg. Section 1.409A-1(i)), then with regard to any
payment that is required to be delayed pursuant to Code Section 409A(a)(2)(B) (the “Delayed Payments”), such payment shall not be made prior to the earlier of (i) the expiration of the six (6)-month period measured from
the date of Executive’s “separation from service” and (ii) the date of Executive’s death. Any payments other than the Delayed Payments shall be paid in accordance with the normal payment dates specified herein. In no case
will the delay of any of the Delayed Payments by Company constitute a breach of Company’s obligations to Executive. 

  

	 	(iii)	If the sixty (60)-day period following a “separation from service” begins in one calendar year and ends in a second calendar year (a “Crossover 60-Day Period”) and if there are any
Subject Payments due Executive that are: (i) conditioned on Executive signing and not revoking a release of claims and (ii) otherwise due to be paid during the portion of the Crossover 60-Day Period that falls within the first year, then
such payments will be delayed and paid in a lump sum during the portion of the Crossover 60-Day Period that falls within the second year. 

  

	 	(iv)	Lump-sum severance payments shall be made, and installment severance payments initiated, within sixty (60) days following Executive’s “separation from service”. 

 

	 	(v)	The Executive’s right to receive installment payments pursuant to this Agreement shall be treated as a right to receive a series of separate and distinct payments. 

 

	 	(vi)	Whenever a payment under this Agreement specifies a payment period with reference to a number of days, the actual date of payment within the specified period shall be within the sole discretion of Company.

  

	 	(vii)	Notwithstanding any other provision of this Agreement to the contrary, in no event shall any Subject Payment be subject to offset by any other amount unless otherwise permitted by Section 409A. 

 

	 	(viii)	Notwithstanding anything herein to the contrary, in regard to Subject Payments, the definition of Change in Control set forth herein shall not be broader than the definition of “change in control event”
as set forth under Section 409A, and if a transaction or event does not otherwise fall within such definition of change of control event, it shall not be deemed a Change in Control. 

 

	 	(ix)	 To the extent that any reimbursement or in-kind benefits are Subject Payments: (x) the amount eligible for reimbursement or in-kind benefit in
one calendar year may not affect the amount eligible for reimbursement or 

  
 19 

	 	
in-kind benefit in any other calendar year (except that a plan providing medical or health benefits may impose a generally applicable limit on the amount that may be reimbursed or paid),
(y) the right to reimbursement or an in-kind benefit is not subject to liquidation or exchange for another benefit, and (z) subject to any shorter time periods provided herein, any such reimbursement of an expense or in-kind benefit must
be made on or before the last day of the calendar year following the calendar year in which the expense was incurred. 

7.14.3 If an amendment of this Agreement is necessary in order for it to comply with Section 409A, the parties hereto will
negotiate in good faith to amend this Agreement in a manner that preserves the original intent of the parties to the extent reasonably possible. No action or failure by Company in good faith to act, pursuant to this Section 7.14, shall subject
Company to any claim, liability, or expense, and Company shall not have any obligation to indemnify or otherwise protect Executive from the obligation to pay any taxes pursuant to Section 409A. 

7.15 Payment by Subsidiaries. Executive acknowledges and agrees that Company may satisfy its obligations to make payments to
Executive under this Agreement by causing one or more of its subsidiaries to make such payments to Executive. Executive agrees that any such payment made by any such subsidiary shall fully satisfy and discharge Company’s obligation to make such
payment to Executive hereunder (but only to the extent of such payment). 
 Signature page follows. 

  
 20 

 [Signature page to Employment Agreement] 

IN WITNESS WHEREOF, the parties have executed this Agreement as of the Signing Date. 

 

			
	EXECUTIVE
	
	/s/ Brian Farley
	Brian Farley
	
	 ALLSCRIPTS HEALTHCARE

SOLUTIONS, INC.

	
	/s/ Deborah Snow 
	By:	 	Deborah Snow 
	Title:	 	 SVP, Marketing, Communications
 and Chief
People Officer

  
 21EX-10.43

 Exhibit 10.43 

SEPARATION AGREEMENT 

This Separation Agreement (this “Agreement”), by and between Clifford B. Meltzer
(“Executive”) and Allscripts Healthcare Solutions, Inc., a corporation organized and existing under the laws of the State of Delaware (“Company”) is effective as of the 5th day of
November, 2013 (the “Effective Date”). Terms used in this Agreement but not specifically defined herein shall have the same meaning as in the Employment Agreement (defined below). 

WHEREAS, Company and Executive entered into an Employment Agreement dated June 17, 2011, as amended May 8, 2012 (the
“Employment Agreement”), a copy of such agreement is attached hereto as Exhibit A; and 
 WHEREAS, Company and
Executive desire to set forth the terms of Executive’s termination of employment with the Company, severance benefits, and other matters related thereto. 

NOW, THEREFORE, in consideration of the foregoing premises, of the mutual agreements and covenants contained herein and for other good and
valuable consideration the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows: 
 1. Termination Date;
Cessation of Duties. 
 (a) Executive’s employment with Company will terminate effective as of the close of business on
December 5, 2013 (the “Termination Date”). As of the Termination Date, Executive’s service as an officer and employment with Company is terminated and Executive irrevocably resigns from all other positions
with any subsidiaries and affiliated companies of Company. 
 (b) Executive’s Employment Agreement remains in full force and effect
until the Termination Date, except as modified by this Agreement. Through and including the Termination Date, Executive shall continue to receive his Base Salary as in effect on the Effective Date and to participate in any benefit plans or programs
of Company provided or made available to Executive as of the Effective Date. 
 (c) As of the Effective Date, Executive is relieved of all
duties for Company, shall take no actions on behalf of Company, and shall have no authority as an officer or agent of Company. Executive’s access to Company’s systems and offices shall cease as of the Effective Date, except to the extent
Executive is invited to the Company offices or given consent to such access by a Company officer on or prior to December 5, 2013. 
 2.
Severance Benefits. Subject to Executive’s compliance with the terms of this Agreement, including without limitation Sections 4, 5, 6, 7, 8, and 10, after the Termination Date, Executive shall receive the payments and benefits set
forth in Section 4.5.1 of the Employment Agreement, which are described and shall be paid or provided in accordance with Schedule 1 attached to this Agreement. 

 3. No Other Payments. Executive expressly acknowledges and agrees that, other than as
specifically provided for in this Agreement and on Schedule 1, no additional payments or benefits are due from Company on any basis whatsoever, including but not limited to no Performance Bonus payment under Company’s 2013 corporate
bonus program, and that Executive’s outstanding, unvested equity awards are forfeited as of the Termination Date, other than as described on Schedule 1. 

4. Release. The pay and benefits provided under Section 2 of this Agreement are subject to Executive’s execution of (without
revocation) and delivery to Company by the forty-fifth (45th) day following the Termination Date (but not before the Termination Date) of a release and waiver of all claims (the “Release”) up to the date of the
Release with such Release in the form attached hereto as Exhibit B. 
 5. Restrictive Covenants. Executive expressly
acknowledges and agrees that Section 5 (“Restrictive Covenants”) of the Employment Agreement remains in full force and effect as provided therein; provided that, for purposes of Section 5 of the Employment
Agreement, the parties agree that a “Competing Organization” shall mean only the organizations identified in the list attached hereto as Exhibit C. 

6. Return of Company Property. Executive represents and warrants that, within seven days of the Effective Date, Executive shall return
to Company all Company property and information in any form (whether, paper, electronic media or otherwise), and not retain copies of any such property or information (excluding, however, information relating solely to Executive’s own
employment, compensation and benefits). 
 7. Non-Disparagement. Executive agrees not to make any adverse or disparaging comments
(oral or written, including but not limited to, via any form of electronic media) about Company, its affiliates, or any of their respective officers, directors, managers or employees which may tend to impugn or injure their reputation, goodwill and
relationships with their past, present and future customers, employees or vendors or with the business community generally. The Company agrees to instruct those individuals who serve as its executive officers as of the Termination Date not to make
any adverse or disparaging comments (oral or written, including but not limited to, via any form of electronic media) about Executive which may tend to impugn or injure his reputation, good will and business, civic or professional relationships.
Nothing in this Section 7 is intended to prohibit, limit or prevent Executive, Company or the Company’s executive officers from providing truthful testimony in a court of law, to a regulatory or law enforcement agency or pursuant to
a properly issued subpoena, and such testimony would not be deemed to be a violation of this Section 7. 
 8.
Cooperation. Executive agrees to cooperate, within reason, subject to reimbursement by Company of reasonable out of pocket costs and expenses, with Company and its counsel with respect to any matter (including any litigation, investigation or
governmental proceeding) which relates to matters with which Executive was involved during his employment with Company. Such cooperation shall include appearing from time to time at the offices of Company or Company’s counsel for conferences
and interviews and in generally providing the officers of Company and its counsel with the full benefit of Executive’s knowledge with respect to any such matter. Executive agrees to render such cooperation in a timely fashion and at such times
and places as may be mutually agreeable to the parties. The Company agrees to compensate Executive at the rate of five hundred dollars ($500) per hour for Executive’s time 

  
 2 

 
spent rendering such cooperation. Executive’s cooperation shall not require him to give Company more time and attention than may reasonably be accommodated to his work schedule and other
commitments, from time to time. 
 9. Waiver of Any Re-Employment Right. Executive waives all interest in and right to reinstatement
or re-employment with Company and any of its affiliates and agrees that any application for re-employment may be rejected without explanation or liability pursuant to this provision. This waiver shall not apply to any instance where Executive’s
then-current employer becomes acquired by the Company or any of its affiliates, or where the Company desires to re-hire Executive. 
 10.
Nondisclosure. Executive shall not disclose or cause to be disclosed the terms of this Agreement or the negotiations leading to it to any person (other than to his spouse, attorneys or tax advisors, who shall also be bound by this
nondisclosure provision), except pursuant to a lawful subpoena or as otherwise required by law. 
 11. Miscellaneous. 

(a) Binding Effect. This Agreement shall be binding upon each of the parties and upon their respective heirs, administrators,
representatives, executors, successors and assigns, and shall inure to the benefit of each party and to their respective heirs, administrators, representatives, executors, successors and assigns. 

(b) Applicable Law. This Agreement shall be construed in accordance with the laws of the State of Illinois, without regard to the
conflict of law provisions of any jurisdiction. 
 (c) Dispute Resolution. Executive expressly acknowledges and agrees that
Section 7.9 (“Dispute Resolution and Arbitration”) of the Employment Agreement remains in full force and effect and shall apply to this Agreement. 

(d) Scope of Agreement. This Agreement and, as indicated, the Employment Agreement reflect the entire agreement between Executive and
Company with respect to the terms and conditions of Executive’s employment relationship with Company and the termination of such employment relationship and, except as specifically provided herein, supersede all prior agreements and
understandings, written or oral relating to the subject matter hereof. 
 (e) Notices. Any notice pertaining to this Agreement shall
be in writing and shall be given in accordance with Section 7.6 of the Employment Agreement. 
 (f) Waiver of Breach. The waiver
by either party to this Agreement of a breach of any provision of this Agreement shall not operate as or be deemed a waiver of any subsequent breach by such party. Continuation of benefits hereunder by Company following a breach by Executive of any
provision of this Agreement shall not preclude Company from thereafter exercising any right that it may otherwise independently have to terminate said benefits based upon the same violation. 

  
 3 

 (g) Amendment. This Agreement may not be modified or amended except by a writing signed by
the parties to this Agreement. 
 (h) Counterparts. This Agreement may be signed in multiple counterparts, each of which shall be
deemed an original. Any executed counterpart returned by facsimile or PDF shall be deemed an original executed counterpart. 
 (i) No
Third Party Beneficiaries. Unless specifically provided herein, the provisions of this Agreement are for the sole benefit of the parties to this Agreement and are not intended to confer upon any person not a party to this Agreement any rights
hereunder. 
 (j) Terms and Construction. Each party has cooperated in the drafting and preparation of this Agreement. The language in
all parts of this Agreement shall be in all cases construed according to its fair meaning and not strictly for or against either party. 

(k) Admissions. Nothing in this Agreement is intended to be, or will be deemed to be, an admission of liability by Executive or Company
to each other, or an admission that they or any of their agents, affiliates, or employees have violated any state, federal or local statute, regulation or ordinance or any principle of common law of any jurisdiction, or that they have engaged in any
wrongdoing towards each other. 
 (l) Withholding. Company may withhold from any amounts payable under this Agreement such federal,
state and local taxes as may be required to be withheld pursuant to applicable laws or regulations. 
 (m) Severability. The holding
of any provision of this Agreement to be illegal, invalid or unenforceable by a court of competent jurisdiction shall not affect any other provisions of this Agreement, which shall remain in full force and effect. 

(n) Calculations. The terms of Schedule 1 are intended to provide Executive the payments and benefits due per the terms of
Section 4.5.1 of the Employment Agreement and other applicable compensation-related documents per terms applicable to a termination of Executive’s employment without Cause. In the event of manifest error in any calculation reflected on
Schedule 1, Company and Executive agree that the calculation shall be corrected and Executive provided the correct payment or benefit. 

(o) Section 409A of the Code. Executive expressly acknowledges and agrees that Section 7.14 (“Section 409A
of the Code”) of the Employment Agreement remains in full force and effect and shall apply to this Agreement. Executive is a “specified employee” of Company and its affiliates (as defined in Treasury Regulation
Section 1.409A-1(i)), and Executive is therefore subject to a delay in payment until six months after the date of Executive’s separation from service from Company (pursuant to Treasury Regulation Section 1.409A-3(i)(2)(ii)) to receive
payments provided hereunder to the extent such amounts are subject to, and not exempt from, Section 409A. If the sixty (60)-day period following a “separation from service” begins in one calendar year and ends in a second calendar
year (a “Crossover 60-Day Period”), then any severance payments that would otherwise occur during the portion of the Crossover 60-Day Period that falls within the first year will be delayed and paid in a lump sum
during the portion of the Crossover 60-Day Period that falls within the second year. 

  
 4 

 IN WITNESS WHEREOF, this Agreement has been duly executed by the parties as of the dates
respectively set forth below. 
  

							
		 		 		 	ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.
				
	Dated: November 19, 2013	 		 		 	/s/ Deborah D. Snow
		 		 		 	Deborah D. Snow
		 		 		 	Senior Vice President Marketing,
		 		 		 	Communications and Chief People Officer
				
		 		 		 	EXECUTIVE:
				
	Dated: November 19, 2013	 		 		 	/s/ Clifford B. Meltzer
		 		 		 	Clifford B. Meltzer

  
 5 

 SCHEDULE 1 

CASH PAYMENTS 
  

					
	 Amount Payable
	  	 Date[s] Payable
	  	 Comments

	$900,000	  	Paid in twelve equal monthly installments with the first two installments to be paid on the sixtieth (60th) day following December 5, 2013 (the “Termination Date”) and the remaining ten installments to
be paid on the ten following monthly anniversaries of such date.	  	Constituting the payments required by Section 4.5.1(i) of the Employment Agreement (lx (base salary + current target performance bonus) paid over 12 months).

 BENEFITS CONTINUATION 
  

			
	 Benefits Description
	  	 Continuation Period

	Continuation of Executive’s enrollment in health and/or dental insurance benefits immediately prior to the Termination Date, with Executive contributing to such benefits as if he were employed by Company.	  	 Until the earlier of:
  

(i)     the end of the 12-month period following the Termination Date (i.e., through
December 4, 2014); or
  

(ii)    Executive’s failure to make a required contribution within 10 days of written notice
or the COBRA grace period, whichever comes later; or
  

(iii)  the date on which Executive becomes eligible to receive comparable benefits from a subsequent
employer.

  
 Schedule 1 - Page 1

 RESTRICTED STOCK UNIT (“RSU”) AND OPTION VESTING AND FORFEITURE 

 

									
	 	  	 Award
	  	 Vesting Per

Sec. 4.5.1(iii)
 of

Employment
 Agreement
or
 Award
	  	 Delivery of Shares
	  	 RSUs /

Options
 Forfeited

from Award

	1.	  	8/31/2011 Perf.-Based RSU Grant, Relative TSR (12,528 granted)	  	8,352*	  	Upon later of certification of performance by Compensation Committee or sixtieth (60th) day following the Termination Date	  	4,176 cancelled due to performance
					
	2.	  	8/31/2011 Perf.-Based RSU Grant, Revenue and Adjusted Operating Income (25,056 granted)	  	16,704	  	Sixtieth (60th) day following the Termination Date	  	2,376 cancelled due to performance below performance hurdles
					
	3.	  	8/31/2011 Perf.-Based RSU Grant, Adjusted Net Income (37,584 granted)	  	21,263	  	Sixtieth (60th) day following the Termination Date (Performance hurdle satisfied in full)	  	6,925
					
	4.	  	5/1/2012 Perf.-Based RSU Grant (34,440 granted)	  	13,752	  	Sixtieth (60th) day following the Termination Date. (Performance hurdle satisfied in full)	  	12,078
					
	5.	  	5/1/2012 Perf.-Based RSU Grant (34,440 granted)	  	13,752**	  	Upon later of certification of performance by Compensation Committee or sixtieth (60th) day following the Termination Date.	  	12,078
					
	6.	  	5/30/2012 RSU Grant (82,042 granted)	  	41,508	  	 Sixtieth (60th) day following the

Termination Date.
	  	13,187

  
 Schedule 1 - Page 2

									
					
	7.	  	2/20/2013 Stock Option Grant (188,680 granted)	  	84,389	  	N/A***	  	104,291
					
	8.	  	2/20/2013 Perf-Based RSU Grant (62,894 granted)	  	37,507****	  	Upon later of certification of performance by Compensation Committee or sixtieth (60th) day following the Termination Date.	  	25,387

  

	*	Based on relative TSR for the performance periods ending 2/25/2013 and 2/25/2014 and upon certification by Compensation Committee; actual number of shares vested may vary from the number listed here. 

	**	Provided Adjusted Net Income for 2013 is at least $81.4 million and upon certification by Compensation Committee. 

	***	90-day post-termination exercise period. 

	****	Based on relative TSR for the performance period ending 2/20/2014 and upon certification by Compensation Committee; actual number of shares vested may vary from the number listed here. 

  
 Schedule 1 - Page 3

 EXHIBIT A 

EMPLOYMENT AGREEMENT AND AMENDMENT 

 EXHIBIT B 

GENERAL RELEASE 

WHEREAS, this General Release (this “Release”) is given by Clifford B. Meltzer
(“Executive”) on the date indicated below at Executive’s signature, pursuant to the Separation Agreement between Allscripts Healthcare Solutions, Inc. (the “Company”) and Executive
effective as of November 5, 2013 (the “Agreement”); and 
 WHEREAS, in consideration for the
payments and benefits provided by Company to Executive under the Agreement, which are conditioned upon his execution of a release and waiver of claims for the benefit of Company, Executive agrees to execute this Release. 

NOW THEREFORE, in consideration of the mutual covenants contained under the Agreement and other good and valuable consideration, the
sufficiency and receipt of which are hereby acknowledged, and intending to be legally bound, Executive agrees as follows: 
 1. In exchange
for the benefits described in the Agreement, Executive hereby agrees to WAIVE any and all rights in connection with, and to fully RELEASE and forever discharge Company and its predecessors, parents, subsidiaries, divisions, related or affiliated
companies, benefit plans, plan administrators and other plan fiduciaries, officers, directors, stockholders, members, employees, heirs, successors, assigns, representatives, agents and counsel (the “Released Parties”)
from any and all torts, contracts, claims, suits, actions, causes of action, demands, rights, damages, costs, expenses, attorneys’ fees, and compensation in any form whatsoever, whether now known or unknown, in law or in equity, which Executive
has or ever had (from the beginning of time through and including the date hereof) against any of the Released Parties, including without limitation on account of or in any way arising out of, relating to or in connection with
Executive’s employment by or separation of employment from any of the Released Parties, and any and all claims for damages or injury to any entity, person, property or reputation arising therefrom, claims for wages, employment benefits, tort
claims and claims under Title VII of the Civil Rights Act of 1964, the Civil Rights Act of 1991, the Civil Rights Act of 1866, the Employee Retirement Income Security Act of 1974 (except that Executive does not waive his right to receive notices and
disclosures, monies and other benefits due in accordance with any employee retirement or welfare benefit plan), the National Labor Relations Act, the Fair Labor Standards Act, the Rehabilitation Act of 1973, the Family and Medical Leave Act of 1993,
the Americans with Disabilities Act of 1990 and any other federal, state or local law, statute, ordinance, guideline, regulation, order or common-law principle of any state relating to employment, employment contracts, wrongful discharge or any
other matter; provided, however, that the foregoing waiver and release shall not apply to Executive’s rights in respect of any benefit or claim to which Executive is entitled under employee pension or welfare benefit plans and
programs of the Released Parties in which Executive is a participant prior to the date below, or to Executive’s rights to enforce the Agreement. 

2. Release of Age Discrimination Claims. In further consideration of the promises made by Company in the Agreement, Executive
specifically WAIVES any and all rights in connection with, and fully RELEASES and forever discharges the Released Parties from, any and all torts, contracts, claims, suits, actions, causes of action, demands, rights, damages, costs,

  
 B-1 

 
expenses, attorneys’ fees, and compensation in any form whatsoever, whether now known or unknown, in law or in equity, which Executive has or ever had (from the beginning of time through and
including the date hereof) against any of the Released Parties, arising under the Age Discrimination in Employment Act of 1967, as amended, 29 U.S.C. Sec. 621, et seq. (“ADEA”). Executive further agrees that:

 (a) Executive’s waiver of rights under this Release is knowing and voluntary and in compliance with the Older Workers Benefit
Protection Act of 1990; 
 (b) Executive understands the terms of this Release; 

(c) the consideration provided in the Agreement represents consideration over and above that to which Executive otherwise would be entitled,
that the consideration would not have been provided had Executive not signed this Release, and that the consideration is in exchange for the signing of this Release; 

(d) Company is hereby advising Executive in writing to consult with Executive’s attorney prior to executing this Release; 

(e) Company is giving Executive a period of at least forty-five (45) days within which to consider this Release; 

(f) Following the execution of this Release Executive has seven (7) days in which to revoke this Release by written notice. To be
effective, the revocation must be made in writing and delivered to and received by the General Counsel, Allscripts Healthcare Solutions, Inc., 222 Merchandise Mart Plaza, Suite 2024, Chicago, Illinois 60654, no later than 4:00 p.m. on the
seventh day after Executive executes this Release. An attempted revocation not actually received by the General Counsel before the revocation deadline will not be effective; and 

(g) This entire Release shall be void and of no force and effect if Executive chooses to so revoke, and, if Executive chooses not to so revoke,
this Release shall then become fully effective and enforceable. 
 This Section 2 does not waive rights or claims that may arise under
the ADEA after the date Executive signs this Release. In addition, nothing in this Release shall in any way affect Executive’s right to indemnification, coverage and expense advancement to the extent provided by Company’s operating
agreement or other applicable Company or insurance policies; provided, however, that Company shall not be liable, and shall not provide a defense and indemnification for any claim wherein Executive has not satisfied the applicable
standard of conduct set forth in such operating agreement or other applicable policies, or wherein Executive has committed any acts of fraud, embezzlement or gross misconduct. 

3. Proceedings; No Admissions. 

(a) Executive hereby represents and warrants that he has no pending claims against any of the Released Parties with any municipal, state,
federal or other governmental or nongovernmental entity. Notwithstanding anything to the contrary, this Release shall not prevent Executive from (A) initiating or causing to be initiated on Executive’s behalf any complaint,

  
 B-2 

 
charge, claim or proceeding against any of the Released Parties before any local, state or federal agency, court or other body challenging the validity of the waiver of Executive’s claims
under the ADEA contained in this Release (but no other portions of the waivers and releases described in Sections 1 or 2); or (B) initiating or participating in an investigation or proceeding conducted by the Equal Employment Opportunity
Commission with respect to the ADEA. 
 (b) Both parties acknowledge and agree that this Release does not constitute, is not intended to be,
and shall not be construed, interpreted or treated in any respect as, and shall not be admissible in any proceeding as, an admission of liability, error, violation, omission or wrongdoing by either party for any purpose whatsoever. Further, both
parties acknowledge and agree that there has been no determination that either party has violated any federal, state or local law, statute, ordinance, guideline, regulation, order or common-law principle. Executive further acknowledges that no
precedent, practice, policy or usage shall be established by this Release or the offer to Executive of compensation and benefits in the Agreement. 

4. Effect of Claim. Executive also understands and agrees that in the event Executive, by himself, or in conjunction with
Executive’s heirs, spouse, family members, executors, or administrators, attempt(s) to institute or institute(s) any charge, claim, suit or action against any of the Released Parties in violation of this Release, Executive shall be obligated,
as an express condition of bringing such action, to tender back to Company the full amount of the compensation and benefits that Executive has received under the Agreement; and Executive further agrees that Executive will pay all of the Released
Parties’ costs, expenses and fees of defending against such action, including, among other things, reasonable attorneys’ fees. The immediately prior sentence does not apply to claims under ADEA or to challenge the release of ADEA claims
under this Release; provided, however, nothing in this Release is intended to reflect any party’s belief that Executive’s waiver of claims under ADEA is invalid or unenforceable under this Release, it being the intent of Executive and
Company that such claims are waived. This Section 4 does not grant Executive an option to return the money and institute an action. Instead this paragraph merely creates an additional term and condition precedent to bringing an action
regardless of the fact that such action is expressly barred by this Release, and is without merit. 
 5. Executive’s Right to
Enforce Agreement. Nothing in this Release shall be construed as a waiver or release by Executive of any claim or right to enforce the terms of the Agreement or to bring a claim for damages arising out of Company’s breach of the
Agreement. 

  
 B-3 

 IN WITNESS WHEREOF, Executive has executed and delivered this Release on the date set forth
below. 
  

							
		 		 		 	NOT TO BE SIGNED PRIOR TO DECEMBER 5, 2013
				
	Date:                             	 		 		 	 
		 		 		 	Clifford B. Meltzer

  
 B-4 

 EXHIBIT C 

For purposes of the Restrictive Covenants set forth in Section 5 of the Employment Agreement, any of the following companies, or any of their
subsidiaries or affiliates, shall be Competing Organizations: 
  

	1.	Aetna* 

  

	2.	Amazing Charts 

  

	3.	athenahealth Inc. 

  

	4.	Cerner Corporation 

  

	5.	CPSI 

  

	6.	CSC* 

  

	7.	Danaher Corporation 

  

	8.	Dell* 

  

	9.	eClinicalWorks Inc. 

  

	10.	e-MDs 

  

	11.	Emdeon Business Services LLC 

  

	12.	Epic Systems Corporation 

  

	13.	Fujitsu* 

  

	14.	General Electric Company* 

  

	15.	Greenway Medical 

  

	16.	Humedica, Inc. 

  

	17.	IBM* 

  

	18.	McKesson Corporation 

  

	19.	Meditech 

  

	20.	Microsoft* 

  

	21.	NextGen 

  

	22.	OPTUMinsight 

  

	23.	Oracle* 

  

	24.	Philips* 

  

	25.	Practice Fusion 

  

	26.	Quality Systems, Inc. 

  

	27.	SAP* 

  

	28.	Siemens* 

  

	29.	The Trizetto Group. Inc.* 

  

	30.	UnitedHealth 

  

	31.	Vitera Healthcare Solutions 

  

	32.	Wellsoft Corporation 

  

	33.	Xerox* 

  

	*	The restriction only applies to the extent that Executive’s employment or services relate to electronic health records, practice management systems or revenue cycle management software for physician offices or
hospitals. 

  
 C-1

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00227-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00227-of-00352.parquet"}]]